Medicine Science (Dec 2017)

Evaluation of drug adherence in patients with non-valvular atrial fibrillation according to geographic regions of Turkey: an analysis from NOAC-TR study

  • Volkan Emren,
  • Mehdi Zoghi,
  • Gonul Aciksari,
  • Abdullah Aslan,
  • Baris Celebi,
  • Murat Bilgin,
  • Oktay Senoz,
  • Ilgin Karaca,
  • Abdurrahman Akyuz,
  • Salih Kilic,
  • Sinan Inci

DOI
https://doi.org/10.5455/medscience.2017.06.8642
Journal volume & issue
Vol. 6, no. 4
pp. 689 – 695

Abstract

Read online

Drug adherence to novel oral anticoagulants (NOAC) varied by countries and popuplations. As a result of NOAC-TR study, in Turkey, drug adhrence to NOACs is poor comparing to other real world studies. However it is not known whether there is a difference between geographic regions of Turkey in terms of NOAC adherence. In this study we aim to investigate the NOAC adherence in patients with non-valvular atrial fibrillation according to the geographic regions in Turkey Method: This cros-sectional study was designed as a subgroup study of NOAC-TR (Drug Adherence in patients with non valvular atrial fibrillation taking non-vitamin K antagonist oral anticoagulants in Turkey). A total of 2802 patients (59% female) taking NOAC (Dabigatran, apixaban, rivaroxaban) due to NVAF at least 3 months, were included. Morisky-8 item drug adherence scale was used. Patients were divided in 3 groups (high, moderate and low adherent) based on drug adherence Results: Of the patients 24% were adherent, 26% were moderate adhererent and 50% were low adherent to NOAC treatment. Drug adhrence was different between geographic regions (p [Med-Science 2017; 6(4.000): 689-695]

Keywords